Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (23)
Oluwayemisi Esan, Adie Viljoen & Anthony S. Wierzbicki. (2022) Colesevelam – a bile acid sequestrant for treating hypercholesterolemia and improving hyperglycemia. Expert Opinion on Pharmacotherapy 23:12, pages 1363-1370.
Read now
Read now
Han Yang, Nan Li, Youlian Zhou, Zhilan Xiao, Haoming Tian, Ming Hu & Sheyu Li. (2020) Cost-Effectiveness Analysis of Ezetimibe as the Add-on Treatment to Moderate-Dose Rosuvastatin versus High-Dose Rosuvastatin in the Secondary Prevention of Cardiovascular Diseases in China: A Markov Model Analysis. Drug Design, Development and Therapy 14, pages 157-165.
Read now
Read now
Henriette Holst Nerild, Mikkel Bring Christensen, Filip Krag Knop & Andreas Brønden. (2018) Preclinical discovery and development of colesevelam for the treatment of type 2 diabetes. Expert Opinion on Drug Discovery 13:12, pages 1161-1167.
Read now
Read now
M. Ruscica, N. Ferri, C. Macchi, A. Corsini & C. R. Sirtori. (2018) Lipid lowering drugs and inflammatory changes: an impact on cardiovascular outcomes?. Annals of Medicine 50:6, pages 461-484.
Read now
Read now
Harold E Bays. (2014) Lowering low-density lipoprotein cholesterol levels in patients with type 2 diabetes mellitus. International Journal of General Medicine 7, pages 355-364.
Read now
Read now
Ye-Fong Du, Horng-Yih Ou, Elizabeth A Beverly & Ching-Ju Chiu. (2014) Achieving glycemic control in elderly patients with type 2 diabetes: a critical comparison of current options. Clinical Interventions in Aging 9, pages 1963-1980.
Read now
Read now
Yellela S. R. Krishnaiah, Yongsheng Yang, Srikant Bykadi, Vilayat A. Sayeed & Mansoor A. Khan. (2014) Comparative evaluation of in vitro efficacy of colesevelam hydrochloride tablets. Drug Development and Industrial Pharmacy 40:9, pages 1173-1179.
Read now
Read now
Linda Dayer-Berenson & Mary Finckenor. (2014) Expanded Colesevelam Administration Options With Oral Suspension Formulation for Patients With Diabetes and Hypercholesterolemia. Postgraduate Medicine 126:3, pages 126-134.
Read now
Read now
Robert J. Romanelli, Angela Leahy, Trevor Jukes, Xin Ye, Chunlin Qian & Denis Y. Ishisaka. (2013) Colesevelam in the treatment of hypercholesterolemia and hyperglycemia: a retrospective analysis from an ambulatory care medical network. Current Medical Research and Opinion 29:12, pages 1747-1756.
Read now
Read now
Harold E Bays. (2012) Long-term (52–78 weeks) treatment with colesevelam HCl added to metformin therapy in type 2 diabetes mellitus patients. Diabetes, Metabolic Syndrome and Obesity 5, pages 125-134.
Read now
Read now
Adie Viljoen & Anthony S Wierzbicki. (2010) Colesevelam: an improved bile acid sequestrant for treating hypercholesterolemia and improving diabetes. Expert Review of Endocrinology & Metabolism 5:6, pages 825-834.
Read now
Read now
TR Bates, VM Connaughton & GF Watts. (2009) Non-adherence to statin therapy: a major challenge for preventive cardiology. Expert Opinion on Pharmacotherapy 10:18, pages 2973-2985.
Read now
Read now
Joel C Marrs. (2009) Colesevelam for the management of Type 2 diabetes. Expert Opinion on Drug Metabolism & Toxicology 5:2, pages 187-194.
Read now
Read now
Robert R. Henry. (2008) Evolving concepts of type 2 diabetes management with oral medications: new approaches to an old disease. Current Medical Research and Opinion 24:8, pages 2189-2202.
Read now
Read now
Harold E Bays, David Neff, Joanne E Tomassini & Andrew M Tershakovec. (2008) Ezetimibe: cholesterol lowering and beyond. Expert Review of Cardiovascular Therapy 6:4, pages 447-470.
Read now
Read now
M. Florentin, E. N. Liberopoulos, D. P. Mikhailidis & M. S. Elisaf. (2008) Colesevelam hydrochloride in clinical practice: a new approach in the treatment of hypercholesterolaemia. Current Medical Research and Opinion 24:4, pages 995-1009.
Read now
Read now
Harold Bays & Peter H Jones. (2007) Colesevelam hydrochloride: reducing atherosclerotic coronary heart disease risk factors. Vascular Health and Risk Management 3:5, pages 733-742.
Read now
Read now
Harold E. Bays & David E. Cohen. (2007) Rationale and design of a prospective clinical trial program to evaluate the glucose-lowering effects of colesevelam HCl in patients with type 2 diabetes mellitus. Current Medical Research and Opinion 23:7, pages 1673-1684.
Read now
Read now
Harold Bays, James Rhyne, Stacey Abby, Yu-Ling Lai & Michael Jones. (2006) Lipid-lowering effects of colesevelam HCl in combination with ezetimibe. Current Medical Research and Opinion 22:11, pages 2191-2200.
Read now
Read now
Annemarie Armani & Peter P Toth. (2006) Colesevelam hydrochloride in the management of dyslipidemia. Expert Review of Cardiovascular Therapy 4:3, pages 283-291.
Read now
Read now
Harold Bays, James McKenney & Michael Davidson. (2005) Torcetrapib/atorvastatin combination therapy. Expert Review of Cardiovascular Therapy 3:5, pages 789-820.
Read now
Read now
Harold Bays & Evan A Stein. (2003) Pharmacotherapy for dyslipidaemia – current therapies and future agents. Expert Opinion on Pharmacotherapy 4:11, pages 1901-1938.
Read now
Read now
Pedro Iglesias & Juan J Díez. (2003) New drugs for the treatment of hypercholesterolaemia. Expert Opinion on Investigational Drugs 12:11, pages 1777-1789.
Read now
Read now
Articles from other publishers (4)
Dhiraj Kumar Sah, Archana Arjunan, Sun Young Park & Young Do Jung. (2022) Bile acids and microbes in metabolic disease. World Journal of Gastroenterology 28:48, pages 6846-6866.
Crossref
Crossref
Runze Zhao, Xiaoyue Ning, Mengqi Wang, Huanhuan Wang, Guang Xing, Li Wang, Chengzhi Lu, Ao Yu & Yongjian Wang. (2022) A ROS-Responsive Simvastatin Nano-Prodrug and its Fibronectin-Targeted Co-Delivery System for Atherosclerosis Treatment. ACS Applied Materials & Interfaces 14:22, pages 25080-25092.
Crossref
Crossref
Alan G. Hendrick, Ilka Müller, Henriëtte Willems, Philip M. Leonard, Steve Irving, Richard Davenport, Takashi Ito, Jenny Reeves, Susanne Wright, Vivienne Allen, Stephen Wilkinson, Helen Heffron, Richard Bazin, Jennifer Turney & Philip J. Mitchell. (2016) Identification and Investigation of Novel Binding Fragments in the Fatty Acid Binding Protein 6 (FABP6). Journal of Medicinal Chemistry 59:17, pages 8094-8102.
Crossref
Crossref
James R. GavinIIIIII, Michael R. Jones, Daniel M. Ford & Kenneth E. Truitt. (2014) Safety and Efficacy of Colesevelam HCl in the Treatment of Elderly Patients. Drugs & Aging 31:6, pages 461-470.
Crossref
Crossref